Form 8-K - Current report:
SEC Accession No. 0001628280-17-008600
Filing Date
2017-08-11
Accepted
2017-08-11 17:01:41
Documents
1
Period of Report
2017-08-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - CARDIOXANE SHIPMENTS a8k-carioxaneshipments.htm 8-K 25232
  Complete submission text file 0001628280-17-008600.txt   26236
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 171025886
SIC: 2834 Pharmaceutical Preparations